Aurora Cannabis Inc. Makes Another Big Acquisition as it Continues to Take Over the Industry

Aurora Cannabis Inc. (TSX:ACB) completed another big deal this week, as the company looks to grow via acquisition.

| More on:

Aurora Cannabis Inc. (TSX:ACB) continues to wheel and deal, as it looks to establish its position at the top of the cannabis industry. Fresh off an acquisition earlier this year, Aurora continues to be relentless in its pursuit of market share, as this week it announced that it would be acquiring MedReleaf Corp. (TSX:LEAF) for $3.2 billion in what is the biggest acquisition in the industry.

The deal is all in stock, which shouldn’t be a surprise to investors given that Aurora doesn’t even have a quarter of a million dollars in cash on its books. We’re still likely to see many acquisitions take place in the industry, as the market is still very fragmented with companies looking to battle it out for customers once legalization takes place.

With sales of just $42 million in the trailing 12 months, MedReleaf is being valued at a price-to-sales multiple of over 76, which would suggest that Aurora is paying a big premium for the medical marijuana company. However, the sad reality is that this not a high valuation given what we’ve seen in the industry so far, and it’s only a little higher than the 73 times sales that Aurora paid in its previous purchase.

Significant growth potential

Combined, the two companies together would be able to produce an estimated 570,000 kg of pot per year. Aurora’s CEO Terry Booth is optimistic that the deal will mean big things for the company — not just in Canada, but globally as well. Booth stated, “This is a transformational transaction that brings together two pioneering cannabis companies, both committed to high technology, high-quality and low-cost production, to create a powerful platform for accelerated growth and success on a global scale.”

While recreational pot is not legal just yet, cannabis for medicinal purposes is, and it has many opportunities to grow, as many people use the drug for pain relief, and we’ve even seen Shoppers Drug Mart ink deals with cannabis companies, including Aurora, in anticipation of the opportunities that will exist for pot in its industry.

Investor reactions remain mild

By the end of trading on Monday, there wasn’t much of a movement from either stock, as investors appeared unconvinced that the deal will go through, as it still requires the approval of shareholders.

Should you consider buying Aurora or MedReleaf today?

While valuations have come down in the industry from their astronomical values last year, prices still remain high given the level of sales that have been generated by cannabis companies, and profits in the industry have been scarce. And while optimism is high that growth will be significant, I’m skeptical about how much demand there will be — both domestically and around the world.

With many cannabis companies flooding the TSX, and competition being significant, it’s not going to be easy to gain market share with barriers to entry being minimal for those that want to start growing their own pot. Aurora may have amassed significant production capacity, but it could just be creating an inventory problem if it has no one to sell all that pot to.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned.

More on Investing

ETF stands for Exchange Traded Fund
Investing

Here’s the Average TFSA Balance at Age 54 in Canada

Here are two ways to optimize your TFSA for either growth or income via ETFs.

Read more »

oil and gas pipeline
Energy Stocks

Where Will Enbridge Stock Be in 3 Years?

After 29 straight years of increasing its dividend and a current yield of 6%, here's why Enbridge is one of…

Read more »

An investor uses a tablet
Tech Stocks

Canadian Tech Stocks to Buy Now for Future Gains

Not all tech stocks are created equal. In fact, these three are valuable options every investor should consider.

Read more »

calculate and analyze stock
Dividend Stocks

This 5.5% Dividend Stock Pays Cash Every Single Month!

This REIT may offer monthly dividends, but don't forget about the potential returns in the growth industry its involved with.

Read more »

concept of real estate evaluation
Stocks for Beginners

2 No-Brainer Real Estate Stocks to Buy Right Now for Less Than $1,000

These two real estate sector-focused stocks have the potential to deliver strong returns on your investments in the coming years.

Read more »

Pumpjack in Alberta Canada
Energy Stocks

Is Enbridge Stock a Buy, Sell, or Hold for 2025?

Enbridge stock just hit a multi-year high.

Read more »

Silver coins fall into a piggy bank.
Dividend Stocks

How to Use Your TFSA to Earn up to $6,000 Per Year in Tax-Free Passive Income

A high return doesn't mean you have to make a high investment -- or a risky one -- especially with…

Read more »

Asset Management
Stock Market

3 of the Best Canadian Stocks to Buy Right Now

Are you looking for stocks that could be a major bargain right now? These three Canadian stocks could provide some…

Read more »